Stay updated with breaking news from Updated May. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Trump Media, the company behind Truth Social, were volatile a day after his historic conviction. It's an early test of how committed his supporters will actually be in owning the shares.
U.S. label update includes superior progression-free survival results from the Phase 3 ALPINE head-to-head trial of BRUKINSA versus IMBRUVICA® in Relapsed or Refractory CLL ALPINE is the only...
What lifestyle modifications and treatment options should patients be educated on for migraine prevention and recurrence?
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial ELREXFIO is an off-the-shelf ,...
08.12.2023 - Pfizer Inc. (NYSE:PFE) today announced the European Commission (EC) has granted conditional marketing authorization for ELREXFIO (elranatamab). ELREFXIO is a targeted immunotherapy for the treatment of adult patients with relapsed and refractory ...